FOI release

Scientific policy in drug development testing

Case reference FOI2025/00109

Received 9 February 2025

Published 31 March 2025

Request

The Animals in Science Committee as the responsible committee for policy direction under the Carltona Principle to the Home Secretary, participated in and organised a Future Futures workshop in 2021. The published pack included various workstreams Under the area "Drug Development Crisis " the workstream stated that " One of the key challenges is the lack of a clear scientific strategy to demonstrate how the different NAMS can be pieced together to replace all the various animal tests that are currently required to test a single new drug." Ergo by the same rationale there must a clear scientific strategy using animal testing existing and in use with which to replace this with NAMS, that the Government expects and indeed must be using to regulate the process of drug development here in the UK and for sale around the world. Please could I ask under Freedom of Information request, if you could point me to the clear scientific strategy that demonstrates how and which animal tests are currently required to test a single new drug please? This must surely be available to drug development manufacturers to enable them to reach regulatory standards and to gain market approval.

Response

see attatched

Documents

• FOI2025_00109 redacted for publication.pdf (102.9 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.